FDA Grants Full Approval to Novavax’s Nuvaxovid Vaccine with Specific Age and Risk-Conditions Restrictions 1 year ago AnaIn FDA ApprovalsFeatured Analysis
New Data Suggests Aficamten Improves Symptoms in Obstructive Hypertrophic Cardiomyopathy Across Diverse Patient Groups 1 year ago AnaIn Biopharma HighlightsBreaking NewsClinical TrialsResearch Updates
Novel Bayesian Hybrid Design Could Speed Up Multinational Trials While Preserving Rigor 1 year ago AnaIn InnovationPharma Industry Updates
New Hope for Rett Syndrome: TSHA-102 Pivotal Trial Moves into Site Activation Stage 1 year ago AnaIn Clinical TrialsInnovationStartups
Bharat Biotech’s Hillchol Oral Cholera Vaccine Clears Phase III with Strong Protection 1 year ago AnaIn Clinical TrialsResearch UpdatesVenture Capital
AbCellera Gets Green Light in Canada for First-in-Human Trial of ABCL635 to Treat Menopause Vasomotor Symptoms 1 year ago AnaIn Clinical Trials
EMA Greenlights Moleculin’s Phase IIb/III Trial of Annamycin Plus Ara-C in AML 1 year ago AnaIn Breaking News
FDA Grants Approval to Emrelis (Telisotuzumab Vedotin) for Advanced NSCLC with c-Met Overexpression 1 year ago AnaIn FDA ApprovalsResearch Updates
New Data from Votoplam (PTC518) Offers Hope for Huntingtin Reduction in Huntington’s Disease 1 year ago AnaIn Clinical Trials
Merus’ Petosemtamab Plus Keytruda Shows Strong Responses in Head and Neck Cancer Phase II Trial 1 year ago AnaIn Biopharma HighlightsResearch UpdatesTop Stories
FDA Approves First Targeted Therapy for KRAS-Mutated Low-Grade Serous Ovarian Cancer 1 year ago AnaIn Breaking NewsClinical TrialsFDA Approvals
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools 1 year ago AnaIn AI & DataInvestments
BioAge Labs Advances Aging-Biology Pipeline with Lead Candidate BGE-102, Eyes Phase 1 by Year-End 1 year ago AnaIn InnovationTop Stories
Pliant Therapeutics Cuts Staff Drastically After Phase 2b Trial Suspension Over Safety Signals 1 year ago AnaIn PeopleResearch UpdatesTop Stories
Pacibekitug Shows Deep, Durable Inflammation Reduction in Phase 2 Trial Among CKD Patients 1 year ago AnaIn Biopharma HighlightsClinical Trials
